Real-time enrollment status for this grin-related neurodevelopmental disorder clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 6:33 AM UTC
| NCT Number | NCT07224581 |
| Recruiting Status | Recruiting |
| Condition | GRIN-related Neurodevelopmental Disorder |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 17 sites in the US |
| Sponsor | GRIN Therapeutics, Inc. |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 30, 2026: Clinical trial NCT07224581 is currently recruiting participants. This phase3 study for grin-related neurodevelopmental disorder is actively seeking new participants at 17 locations across the United States. The study is sponsored by GRIN Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07224581 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07224581 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.